Blue Flower Director Will Pomerantz Will Helm PTC's Nymph Errant

News   Blue Flower Director Will Pomerantz Will Helm PTC's Nymph Errant
Will Pomerantz, director of The Blue Flower at Prospect Theater Company and Second Stage, will direct Prospect's upcoming production of Cole Porter's 1933 musical Nymph Errant. Performances will begin July 7 at the Clurman Theatre at Theatre Row.

Nymph Errant, featuring music and lyrics by Porter, will be presented with a new libretto by Rob Urbinati, which will be based on the novel by James Laver and the original libretto by Romney Brent.

Casting will be announced at a later date. The musical will play a limited engagement through July 29.

Here's how PTC bills the production: "One of Porter's most sexy and sophisticated scores – originally censored in its London debut – will be premiered in this sleek new adaptation. From a Swiss boarding school to an Austrian nudist colony to a Turkish harem, follow the unlikely adventures of young Evangeline Edwards as she enters the world and seeks her true passion in this fresh take on a rarely-heard gem."

Other members of the creative team include musical director Jim Bassi (Lincoln Center’s Twelve Dreams), lighting designer Cory Pattak (Newsies, Peter and the Starcatcher), set designer Brian Prather (Fair Game) and costume designer Whitney Locher (Barrow Street's Cymbeline).

Pomerantz has directed world premieres by playwrights such as John Guare, David Auburn, Neil LaBute, Craig Lucas, Kia Corthron, David Lindsay-Abaire, Stephen Belber, Noah Haidle, Linda Cho and Kira Obolensky. His production of The Blue Flower, which premiered at Prospect, won Elliot Norton and Independent Reviewers of New England (I.R.N.E.) Awards. Nymph Errant is the third production in Prospect's 2011-12 season, following Adam Guettel's Myths and Hymns and the musical comedy Iron Curtain by Susan DiLallo, Peter Mills and Stephen Weiner.

The Clurman Theatre at Theatre Row is located at 410 West 42nd Street. For more information and tickets, call (212) 239-6200 or (800) 432-7250 or visit

Today’s Most Popular News: